BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38108151)

  • 1. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction.
    Rush CJ; Berry C; Oldroyd KG; Rocchiccioli JP; Lindsay MM; Touyz RM; Murphy CL; Ford TJ; Sidik N; McEntegart MB; Lang NN; Jhund PS; Campbell RT; McMurray JJV; Petrie MC
    JAMA Cardiol; 2021 Oct; 6(10):1130-1143. PubMed ID: 34160566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Coronary Microvascular Dysfunction With Heart Failure Hospitalizations and Mortality in Heart Failure With Preserved Ejection Fraction: A Follow-up in the PROMIS-HFpEF Study.
    Hage C; Svedlund S; Saraste A; Faxén UL; Benson L; Fermer ML; Gan LM; Shah SJ; Lam CSP; Lund LH
    J Card Fail; 2020 Nov; 26(11):1016-1021. PubMed ID: 32846205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.
    Ahmad A; Corban MT; Toya T; Verbrugge FH; Sara JD; Lerman LO; Borlaug BA; Lerman A
    Eur J Heart Fail; 2021 May; 23(5):765-772. PubMed ID: 32949186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve.
    Gallinoro E; Paolisso P; Candreva A; Bermpeis K; Fabbricatore D; Esposito G; Bertolone D; Fernandez Peregrina E; Munhoz D; Mileva N; Penicka M; Bartunek J; Vanderheyden M; Wyffels E; Sonck J; Collet C; De Bruyne B; Barbato E
    Front Cardiovasc Med; 2021; 8():765071. PubMed ID: 34738020
    [No Abstract]   [Full Text] [Related]  

  • 6. Left atrial volume and left ventricular mass indices in heart failure with preserved and reduced ejection fraction.
    Gehlken C; Screever EM; Suthahar N; van der Meer P; Westenbrink BD; Coster JE; Van Veldhuisen DJ; de Boer RA; Meijers WC
    ESC Heart Fail; 2021 Aug; 8(4):2458-2466. PubMed ID: 34085774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.
    Sinha A; Rahman H; Webb A; Shah AM; Perera D
    Eur Heart J; 2021 Nov; 42(43):4431-4441. PubMed ID: 34529791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study.
    John JE; Claggett B; Skali H; Solomon SD; Cunningham JW; Matsushita K; Konety SH; Kitzman DW; Mosley TH; Clark D; Chang PP; Shah AM
    J Am Heart Assoc; 2022 Sep; 11(17):e021660. PubMed ID: 36000416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and Long-Term Survival After Coronary Artery Bypass Grafting in Women and Men With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Sun LY; Tu JV; Bader Eddeen A; Liu PP
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29909401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction.
    Markley R; Del Buono MG; Mihalick V; Pandelidis A; Trankle C; Jordan JH; Decamp K; Winston C; Carbone S; Billingsley H; Barron A; Thomas G; Van Tassell B; Hundley WG; Kellman P; Abbate A
    Int J Cardiovasc Imaging; 2023 Apr; 39(4):811-819. PubMed ID: 36607469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function on Cardiovascular Death.
    Hong D; Lee SH; Shin D; Choi KH; Kim HK; Ha SJ; Joh HS; Park TK; Yang JH; Song YB; Hahn JY; Choi SH; Gwon HC; Lee JM
    J Am Heart Assoc; 2023 Feb; 12(3):e027690. PubMed ID: 36695307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
    Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional differences and coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Erhardsson M; Ljung Faxén U; Venkateshvaran A; Svedlund S; Saraste A; Lagerström Fermer M; Gan LM; Shah SJ; Tromp J; Sp Lam C; Lund LH; Hage C
    ESC Heart Fail; 2023 Dec; 10(6):3729-3734. PubMed ID: 37920127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?
    Sinha A; Rahman H; Perera D
    Curr Opin Cardiol; 2023 Nov; 38(6):521-526. PubMed ID: 37668191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery disease.
    Michelsen MM; Pena A; Mygind ND; Bech J; Gustafsson I; Kastrup J; Hansen HS; Høst N; Hansen PR; Prescott E
    Echocardiography; 2018 Feb; 35(2):196-203. PubMed ID: 29222822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of Coronary Microvascular Dysfunction and Diffuse Myocardial Fibrosis (Measured by Cardiovascular Magnetic Resonance) in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Löffler AI; Pan JA; Balfour PC; Shaw PW; Yang Y; Nasir M; Auger DA; Epstein FH; Kramer CM; Gan LM; Salerno M
    Am J Cardiol; 2019 Nov; 124(10):1584-1589. PubMed ID: 31575425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular magnetic resonance assessment of coronary flow reserve improves risk stratification in heart failure with preserved ejection fraction.
    Kato S; Fukui K; Kodama S; Azuma M; Nakayama N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D
    J Cardiovasc Magn Reson; 2021 Oct; 23(1):112. PubMed ID: 34657615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary microvascular dysfunction in hypertrophy and heart failure.
    Camici PG; Tschöpe C; Di Carli MF; Rimoldi O; Van Linthout S
    Cardiovasc Res; 2020 Mar; 116(4):806-816. PubMed ID: 31999329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.